User profiles for Tomoyuki Fujisawa

Tomoyuki Fujisawa

浜松医科大学 第二内科
Verified email at hama-med.ac.jp
Cited by 6351

Regulation of airway MUC5AC expression by IL-1β and IL-17A; the NF-κB paradigm

T Fujisawa, S Velichko, P Thai, LY Hung… - The Journal of …, 2009 - journals.aai.org
Mucin over-production is one of the hallmarks of chronic airway diseases such as chronic
obstructive pulmonary disease, asthma, and cystic fibrosis. NF-κB activation in airway …

Cumulative incidence of and predictive factors for lung cancer in IPF

…, T Naito, N Enomoto, D Hashimoto, T Fujisawa… - …, 2009 - Wiley Online Library
Background and objective: Previous studies have indicated a high incidence of lung cancer
in IPF, and some have identified its risk factors. However, those studies were retrospective …

[HTML][HTML] Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases

…, Y Kaida, Y Nakamura, N Enomoto, T Fujisawa… - Respiratory …, 2009 - Elsevier
BACKGROUND: Acute exacerbation (AE) is currently established as a distinct condition
with acute deterioration of respiratory status in idiopathic pulmonary fibrosis (IPF). Recently, …

Phase relations and volume changes of hafnia under high pressure and high temperature

…, H Fukui, T Kunisada, T Fujisawa… - Journal of the …, 2001 - Wiley Online Library
Using multi‐anvil high‐pressure devices and synchrotron radiation, X‐ray in situ observations
of HfO 2 under high pressure and high temperature have been performed to investigate its …

Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.

T Fujisawa, T Suda, Y Nakamura, N Enomoto… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To assess the difference in clinical features and prognosis of patients with
interstitial lung disease (ILD) comparing polymyositis (PM) and dermatomyositis (DM). METHODS…

[HTML][HTML] Prognostic factors for myositis-associated interstitial lung disease

T Fujisawa, H Hozumi, M Kono, N Enomoto… - PLoS one, 2014 - journals.plos.org
Background Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM),
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …

Interstitial lung diseases associated with amyopathic dermatomyositis

T Suda, T Fujisawa, N Enomoto… - European …, 2006 - Eur Respiratory Soc
The aim of the present study was to clarify the clinical characteristics and prognosis of
patients with interstitial lung disease (ILD) associated with amyopathic dermatomyositis (ILD-ADM)…

[HTML][HTML] Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease

H Hozumi, T Fujisawa, R Nakashima, T Johkoh… - Respiratory …, 2016 - Elsevier
Objectives Myositis-specific autoantibodies (MSAs) are associated with clinical phenotypes
in polymyositis/dermatomyositis (PM/DM). No study has investigated the clinical features …

Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study

…, M Kono, D Hashimoto, N Enomoto, T Fujisawa… - BMJ open, 2013 - bmjopen.bmj.com
Objectives To investigate the risk factors and prognosis associated with acute exacerbation (AE)
in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). …

NF-κB Mediates IL-1β– and IL-17A–Induced MUC5B Expression in Airway Epithelial Cells

T Fujisawa, MMJ Chang, S Velichko, P Thai… - American journal of …, 2011 - atsjournals.org
A major pathological feature of chronic airway diseases is the elevated expression of gel-forming
mucins. NF-κB activation in airway epithelial cells has been shown to play a …